14-day Premium Trial Subscription Sign Up For FreeGet Free

Weaker Stock
Today CRBP ranks #17590 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Corbus Pharmaceuticals Holdings Stock Forecast NASDAQ:CRBP

$0.74 (-10.01%)

Volume: 1M

Closed: Dec 03, 2021

Hollow Logo Score: -8.548

Corbus Pharmaceuticals Holdings Stock Forecast

$0.74 (-10.01%)

Volume: 1M

Closed: Dec 03, 2021

Score Hollow Logo -8.548
Which way will CRBP go? Request
Key Stats
P/E Ratio -2.11
Beta 1.77
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Corbus Pharmaceuticals Holdings stock currently holds an RSI14 at 22 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Big movements in Corbus Pharmaceuticals Holdings stock price on Friday moving 18.54% between high and low
(Updated on Dec 03, 2021)

Sell candidate since 2021-11-17 Loss -26.73%

The Corbus Pharmaceuticals Holdings stock price fell by -10.01% on the last day (Friday, 3rd Dec 2021) from $0.82 to $0.74. During the day the stock fluctuated 18.54% from a day low at $0.70 to a day high of $0.83. The price has fallen in 6 of the last 10 days and is down by -19.57% for this period. Volume has increased on the last day by 389 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 million shares were bought and sold for approximately $1.07 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.84) are considered to be a "second chance" to get out. According to the fan-theory $0.62 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Signals & Forecast

There are few to no technical positive signals at the moment. The Corbus Pharmaceuticals Holdings stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.84 and $0.98. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 15, 2021, and so far it has fallen -33.33%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Corbus Pharmaceuticals Holdings gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.13 between high and low, or 18.54%. For the last week, the stock has had a daily average volatility of 9.81%.

Corbus Pharmaceuticals Holdings is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Corbus Pharmaceuticals Holdings stock A Buy?

Corbus Pharmaceuticals Holdings holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -8.548

Predicted Opening Price for Corbus Pharmaceuticals Holdings of Monday, December 6, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price December 6, 2021 Current price
$0.76 $0.74 (Undervalued)
Strong Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Nov 23, 2021 "Royal Bank of Canada" gave "$2.00" rating for CRBP. The price target was changed from $0.88 to 0.5%.

Volatility and Risk
Daily Average Volatility: 9.81 %
Overall Risk: Very High High Medium Low Very Low
9.81 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $0.82
Price: $0.74
No Support Found

CRBP Insider Trading Show all Trades



Last 100 transactions
Buy: 7 586 195 | Sell: 586 066 (Shares)
Date Action Amount Person Type
Jun 17, 2021 Buy 58 200 Holmer Alan F Stock Option (right to buy)
Jun 17, 2021 Buy 58 200 Jacques Rachelle Suzanne Stock Option (right to buy)
Jun 17, 2021 Buy 58 200 Salzmann Peter Stock Option (right to buy)
Jun 17, 2021 Buy 58 200 Catlin Avery W Stock Option (right to buy)
Jun 17, 2021 Buy 58 200 Jenkins John Kenneth Stock Option (right to buy)
Show all Insider Trades


Last 100 transactions
Buy: 7 586 195 | Sell: 586 066 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 0.89 19.78 %
0.84 13.08 %
0.81 8.94 %
Current price: 0.74
Support 0.71 -4.46 %
0.68 -8.60 %
0.63 -15.30 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 0.92 24.32 %
0.88 19.53 %
0.82 11.12 %
Current price 0.74
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes Resunab, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of cystic fibrosis, systemic sclerosis, and skin-predominant dermatomyositis diseases. The company is based in N... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE